Phase 4
Completed N=550
Subcuticular Suture for Cesarean Skin Incision Closure
Complications; Cesarean Section · Surgical Wound Infection
Source: ClinicalTrials.gov NCT02459093 ↗
Enrolled (actual)
550
Serious AEs
0.0%
Results posted
Jun 2018
Primary outcomePrimary: Number of Participants With Wound Complications (Surgical Site Infection (SSI), Hematoma, Separation, Seroma, Etc) — 23; 37; 16; 25 Participants — p=0.04
◆ Published Evidence
Established
31citations · ~3 / year
Comparison of Subcuticular Suture Type for Skin Closure After Cesarean Delivery: A Randomized Controlled Trial.
Summary
A comparison of the type of suture used for cesarean skin incision approximation and the subsequent rate of wound complications has not been widely studied. Investigators seek to compare poliglecaprone 25 and polyglactin 910 suture used in a subcuticular skin closure in Pfannenstiel incisions during cesarean birth and determine the subsequent wound complication rates (SSI, hematoma, seroma, wound separation).
Linked Publications
-
Comparison of Subcuticular Suture Type for Skin Closure After Cesarean Delivery: A Randomized Controlled Trial.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Participants With Wound Complications (Surgical Site Infection (SSI), Hematoma, Separation, Seroma, Etc) |
22; 30; 16; 20; 1; 2 | 0.05 |
Eligibility Criteria
Inclusion Criteria
- Gestational age of 37 completed weeks or greater based on their estimated due date calculated from last menstrual period or early ultrasound.
- Patients participating will be undergoing either:
- Scheduled cesarean delivery
- Non-emergent cesarean delivery
Exclusion Criteria
- Urogenital tract infection within 2 weeks prior to surgery
- Chronic oral or injectable steroid use (> 2 weeks)
- Emergency cesarean delivery (need to deliver immediately due to a maternal or fetal indication)
- Vertical skin incision
- Active participation in another research study
Data sourced from ClinicalTrials.gov (NCT02459093) and the linked publication. Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.